Premium
Biodegradable and bioactive porous scaffold structures prepared using fused deposition modeling
Author(s) -
Korpela Jyrki,
Kokkari Anne,
Korhonen Harri,
Malin Minna,
Närhi Timo,
Seppälä Jukka
Publication year - 2013
Publication title -
journal of biomedical materials research part b: applied biomaterials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.665
H-Index - 108
eISSN - 1552-4981
pISSN - 1552-4973
DOI - 10.1002/jbm.b.32863
Subject(s) - fused deposition modeling , materials science , scanning electron microscope , compressive strength , scaffold , composite number , porosity , composite material , biocompatibility , caprolactone , tissue engineering , biomedical engineering , polymer , 3d printing , copolymer , medicine , metallurgy
Three‐dimensional printing (3DP) refers to a group of additive manufacturing techniques that can be utilized in tissue engineering applications. Fused deposition modeling (FDM) is a 3DP method capable of using common thermoplastic polymers. However, the scope of materials applicable for FDM has not been fully recognized. The purpose of this study was to examine the creation of biodegradable porous scaffold structures using different materials in FDM and to determine the compressive properties and the fibroblast cell response of the structures. To the best of our knowledge, the printability of a poly(ε‐caprolactone)/bioactive glass (PCL/BAG) composite and L ‐lactide/ε‐caprolactone 75/25 mol % copolymer (PLC) was demonstrated for the first time. Scanning electron microscope (SEM) images showed BAG particles at the surface of the printed PCL/BAG scaffolds. Compressive testing showed the possibility of altering the compressive stiffness of a scaffold without changing the compressive modulus. Compressive properties were significantly dependent on porosity level and structural geometry. Fibroblast proliferation was significantly higher in polylactide than in PCL or PCL/BAG composite. Optical microscope images and SEM images showed the viability of the cells, which demonstrated the biocompatibility of the structures. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2013.